403 results
Page 3 of 21
8-K
EX-99.1
ttlcti4p9q0yh4cdx4
4 May 22
Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist
4:17pm
8-K
EX-99.1
lseo48tm uzn1
4 May 22
Jazz Pharmaceuticals Announces First Quarter 2022
4:13pm
8-K
EX-99.1
x1t2ja8yx1xer208
7 Apr 22
Other Events
7:15am
8-K
EX-99.1
tlr3eqfma c7age
28 Mar 22
Jazz Pharmaceuticals Announces Agreement to Divest Sunosi® (solriamfetol) to Axsome Therapeutics
8:55am
S-8
lz3xswz shfamokl4
1 Mar 22
Registration of securities for employees
7:57pm
S-8
c6r6tlm
1 Mar 22
Registration of securities for employees
7:57pm
S-8
EX-5.1
nqni6jb3a9lon zjq7
1 Mar 22
Registration of securities for employees
7:57pm
8-K
EX-99.1
3in4m1z6n
1 Mar 22
Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2021
4:07pm
8-K
EX-99.1
711f3nnr05mvpp4g23c
10 Jan 22
Announces $5 billion revenue target for 2025
7:47am
8-K
EX-99.1
ek72ub0yi8c feikcx05
9 Nov 21
Jazz Pharmaceuticals Announces Third Quarter 2021
4:07pm